Previous New Releases from NCBI BookshelfDarolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer.Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer.